Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
Technetium Tc99m^ teboroxime
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1995
Highly Cited
1995
UNLABELLED
With the introduction of 99mTc-teboroxime, a previously undocumented artifact has shown up in cardiac SPECT imaging… Expand
1994
1994
UNLABELLED
We have examined the feasibility of compartmental analysis of 99mTc-teboroxime kinetics in measuring physiological… Expand
Highly Cited
1993
Highly Cited
1993
Since 201Tl, 99mTc-sestamibi and 99mTc-teboroxime concentrate in cardiac cells through different mechanisms, we compared their… Expand
Highly Cited
1993
Highly Cited
1993
We have developed a method for the detection and correction of translational patient motion in dynamic and static myocardial… Expand
Highly Cited
1993
Highly Cited
1993
Technetium-94m (T1/2 = 53 min) allows the in vivo study of technetium radiopharmaceuticals with positron emission tomography (PET… Expand
1993
1993
Technetium-99m-teboroxime is characterized by a high extraction fraction over a wide range of blood flow rates, rapid myocardial… Expand
Review
1991
Review
1991
In recent years, several technetium 99m-labeled myocardial perfusion agents have been under investigation to determine their… Expand
1991
1991
BackgroundThis study tested the hypotheses in the setting of a coronary artery stenosis that 1) planar 99mTc-teboroxime… Expand
1991
1991
The clearance kinetics of the perfusion tracer 99mTc-teboroxime were evaluated in post-stenotic and normal myocardium using… Expand
Review
1991
Review
1991
The two new 99m (99mTc) labeled myocardial perfusion agents, 99mTc-Sestamibi and 99mTc-Teboroxime, are now available for routine… Expand
